Isoconazole nitrate 50 mg | 99.73%
TargetMol
Isoconazole nitrate
Search Results
Lomerizine dihydrochloride 25 mg | Purity Not Available
TargetMol
Lomerizine dihydrochloride (KB-2796) is an antagonist of L- and T-type voltage-gated calcium channels used to treat migraine.
More Information Supplier PageLomerizine dihydrochloride
Lomerizine dihydrochloride 50 mg | Purity Not Available
TargetMol
Lomerizine dihydrochloride (KB-2796) is an antagonist of L- and T-type voltage-gated calcium channels used to treat migraine.
More Information Supplier PageLomerizine dihydrochloride
N6-methyladenosine 100 mg | Purity Not Available
TargetMol
N6-methyladenosine (NSC-29409) is a methylated adenine residue. N6-Methyladenosine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer.
More Information Supplier PageN6-methyladenosine
N6-methyladenosine 50 mg | Purity Not Available
TargetMol
N6-methyladenosine (NSC-29409) is a methylated adenine residue. N6-Methyladenosine is an endogenous urinary nucleoside product of the degradation of transfer ribonucleic acid (tRNA); urinary nucleosides are biological markers for patients with colorectal cancer.
More Information Supplier PageN6-methyladenosine
Sodium Picosulfate 100 mg | 99.10%
TargetMol
Sodium Picosulfate inhibits absorption of water and electrolytes, and increases their secretion.
More Information Supplier PageSodium Picosulfate
Sodium Picosulfate 50 mg | 99.10%
TargetMol
Sodium Picosulfate inhibits absorption of water and electrolytes, and increases their secretion.
More Information Supplier PageSodium Picosulfate
Tasquinimod 10 mg | 99.50%
TargetMol
Tasquinimod is a quinoline-3-carboxamide linomide analog with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human […]
More Information Supplier PageTasquinimod
Tasquinimod 25 mg | 99.50%
TargetMol
Tasquinimod is a quinoline-3-carboxamide linomide analog with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human […]
More Information Supplier PageTasquinimod
Tasquinimod 50 mg | 99.50%
TargetMol
Tasquinimod is a quinoline-3-carboxamide linomide analog with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human […]
More Information Supplier PageTasquinimod